Envoy Medical Expands Intellectual Property Portfolio to 99 Patents
Envoy Medical, Inc. announced the grant of two additional patents in the United States and Hong Kong, bringing its total global patent portfolio to 99 granted patents.
Stocks · News reference
Envoy Medical announced its financial results for the quarter ended September 30, 2026, and provided an update on its clinical trial progress.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Envoy Medical, Inc. announced the grant of two additional patents in the United States and Hong Kong, bringing its total global patent portfolio to 99 granted patents.
Envoy Medical, Inc. has received notification from The Nasdaq Stock Market confirming it has regained compliance with the minimum bid price requirement.
Envoy Medical, Inc. has scheduled the release of its financial results for the third quarter ended September 30, 2026, for November 5, 2026.